These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 26253518

  • 21. The impact of Clostridium difficile infection on resource use and costs in hospitals in Spain and Italy: a matched cohort study.
    Asensio A, Di Bella S, Lo Vecchio A, Grau S, Hart WM, Isidoro B, Scotto R, Petrosillo N, Watt M, Nazir J.
    Int J Infect Dis; 2015 Jul; 36():31-8. PubMed ID: 26003403
    [Abstract] [Full Text] [Related]

  • 22. Impact of recurrent Clostridium difficile infection: hospitalization and patient quality of life.
    Wilcox MH, Ahir H, Coia JE, Dodgson A, Hopkins S, Llewelyn MJ, Settle C, Mclain-Smith S, Marcella SW.
    J Antimicrob Chemother; 2017 Sep 01; 72(9):2647-2656. PubMed ID: 28633368
    [Abstract] [Full Text] [Related]

  • 23. Variability in testing policies and impact on reported Clostridium difficile infection rates: results from the pilot Longitudinal European Clostridium difficile Infection Diagnosis surveillance study (LuCID).
    Davies K, Davis G, Barbut F, Eckert C, Petrosillo N, Wilcox MH.
    Eur J Clin Microbiol Infect Dis; 2016 Dec 01; 35(12):1949-1956. PubMed ID: 27590621
    [Abstract] [Full Text] [Related]

  • 24. The burden of Clostridium difficile in surgical patients in the United States.
    Zerey M, Paton BL, Lincourt AE, Gersin KS, Kercher KW, Heniford BT.
    Surg Infect (Larchmt); 2007 Dec 01; 8(6):557-66. PubMed ID: 18171114
    [Abstract] [Full Text] [Related]

  • 25. The rise in Clostridium difficile infection incidence among hospitalized adults in the United States: 2001-2010.
    Reveles KR, Lee GC, Boyd NK, Frei CR.
    Am J Infect Control; 2014 Oct 01; 42(10):1028-32. PubMed ID: 25278388
    [Abstract] [Full Text] [Related]

  • 26. Consequences of Clostridium difficile infection: understanding the healthcare burden.
    Bouza E.
    Clin Microbiol Infect; 2012 Dec 01; 18 Suppl 6():5-12. PubMed ID: 23121549
    [Abstract] [Full Text] [Related]

  • 27. Medication risk factors associated with healthcare-associated Clostridium difficile infection: a multilevel model case-control study among 64 US academic medical centres.
    Pakyz AL, Jawahar R, Wang Q, Harpe SE.
    J Antimicrob Chemother; 2014 Apr 01; 69(4):1127-31. PubMed ID: 24327619
    [Abstract] [Full Text] [Related]

  • 28. Healthcare burden of recurrent Clostridioides difficile infection in Japan: A retrospective database study.
    Kunishima H, Ito K, Laurent T, Abe M.
    J Infect Chemother; 2018 Nov 01; 24(11):892-901. PubMed ID: 30190105
    [Abstract] [Full Text] [Related]

  • 29. Assessing the burden of Clostridium difficile infections for hospitals.
    Hebbinckuys E, Marissal JP, Preda C, Leclercq V.
    J Hosp Infect; 2018 Jan 01; 98(1):29-35. PubMed ID: 28890287
    [Abstract] [Full Text] [Related]

  • 30. The prolongation of length of stay because of Clostridium difficile infection.
    Mitchell BG, Gardner A, Barnett AG, Hiller JE, Graves N.
    Am J Infect Control; 2014 Feb 01; 42(2):164-7. PubMed ID: 24290226
    [Abstract] [Full Text] [Related]

  • 31. Attributable burden of hospital-onset Clostridium difficile infection: a propensity score matching study.
    Tabak YP, Zilberberg MD, Johannes RS, Sun X, McDonald LC.
    Infect Control Hosp Epidemiol; 2013 Jun 01; 34(6):588-96. PubMed ID: 23651889
    [Abstract] [Full Text] [Related]

  • 32. Clostridium difficile in the ICU: study of the incidence, recurrence, clinical characteristics and complications in a university hospital.
    Salva S, Duran N, Rodriguez V, Nieto L, Serra J, Rello J, CRIPS Investigators.
    Med Intensiva; 2014 Apr 01; 38(3):140-5. PubMed ID: 23769945
    [Abstract] [Full Text] [Related]

  • 33. Hospital Clostridium difficile infection (CDI) incidence as a risk factor for hospital-associated CDI.
    Miller AC, Polgreen LA, Cavanaugh JE, Polgreen PM.
    Am J Infect Control; 2016 Jul 01; 44(7):825-9. PubMed ID: 26944007
    [Abstract] [Full Text] [Related]

  • 34. The burden of healthcare-associated Clostridium difficile infection in a non-metropolitan setting.
    Bond SE, Boutlis CS, Yeo WW, Pratt WAB, Orr ME, Miyakis S.
    J Hosp Infect; 2017 Apr 01; 95(4):387-393. PubMed ID: 28131640
    [Abstract] [Full Text] [Related]

  • 35. The economic burden of Clostridium difficile.
    McGlone SM, Bailey RR, Zimmer SM, Popovich MJ, Tian Y, Ufberg P, Muder RR, Lee BY.
    Clin Microbiol Infect; 2012 Mar 01; 18(3):282-9. PubMed ID: 21668576
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Recurrent Clostridium difficile infection is associated with increased mortality.
    Olsen MA, Yan Y, Reske KA, Zilberberg MD, Dubberke ER.
    Clin Microbiol Infect; 2015 Feb 01; 21(2):164-70. PubMed ID: 25658560
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Hospital-acquired Clostridium difficile infection: an institutional costing analysis.
    Choi KB, Suh KN, Muldoon KA, Roth VR, Forster AJ.
    J Hosp Infect; 2019 Jun 01; 102(2):141-147. PubMed ID: 30690051
    [Abstract] [Full Text] [Related]

  • 40. Attributable inpatient costs of recurrent Clostridium difficile infections.
    Dubberke ER, Schaefer E, Reske KA, Zilberberg M, Hollenbeak CS, Olsen MA.
    Infect Control Hosp Epidemiol; 2014 Nov 01; 35(11):1400-7. PubMed ID: 25333435
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.